|
|
||||||||
Ann Thorac Surg 1991;51:931-935
© 1991 The Society of Thoracic Surgeons
Department of Surgery, National Cancer Center Hospital, and National Oji Hospital, Tokyo, Japan
Accepted for publication December 28, 1990.
* Address reprint requests to Dr Kato, National Cancer Center Hospital, 1-1 Tsukiji 5-Chome, Chuo-ku, Tokyo, 104, Japan.
We studied a series of 150 patients treated for thoracic esophageal carcinoma at our institution. The patients were divided into two matched groups. Group B underwent transthoracic esophagectomy with mediastinal and abdominal lymphadenectomy only; group A also underwent bilateral neck lymph node dissection. The rates of operative mortality and operative complications did not differ significantly between the two groups. The 5-year survival rate was 38.7% overall (48.7% in group A and 33.7% in group B). Group A had a significantly better survival curve than group B. Twenty patients (26.0%) in group A had metastasis in the dissected neck lymph nodes. The 4-year survival rate of these patients was 47.9%. The significantly better survival of group A and the satisfactory prognosis in the patients with positive cervical lymph nodes demonstrates the effectiveness of neck lymph node dissection in radical operation for thoracic esophageal carcinoma.
This article has been cited by other articles:
![]() |
T. YOKOTA, S. HATOOKA, T. URA, T. ABE, D. TAKAHARI, K. SHITARA, M. NOMURA, C. KONDO, A. MIZOTA, Y. YATABE, et al. Docetaxel plus 5-Fluorouracil and Cisplatin (DCF) Induction Chemotherapy for Locally Advanced Borderline-resectable T4 Esophageal Cancer Anticancer Res, October 1, 2011; 31(10): 3535 - 3541. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Jang, H.-S. Lee, M. S. Kim, J. M. Lee, and J. I. Zo Patterns of Lymph Node Metastasis and Survival for Upper Esophageal Squamous Cell Carcinoma Ann. Thorac. Surg., September 1, 2011; 92(3): 1091 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. SHIMAKAWA, Y. NARITAKA, S. ASAKA, N. ISOHATA, K. YAMAGUCHI, M. MURAYAMA, S. KONNO, T. KATSUBE, K. OGAWA, and H. IDE A Case of Esophageal Cancer with Multiple Lymph Node Metastases which Responded to Neoadjuvant Chemotherapy (DCF therapy) Anticancer Res, January 1, 2010; 30(1): 221 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-T. Fang and W.-H. Chen Current Trends in Extended Lymph Node Dissection for Esophageal Carcinoma Asian Cardiovasc Thorac Ann, April 1, 2009; 17(2): 208 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tachibana, S. Kinugasa, N. Hirahara, and H. Yoshimura Lymph node classification of esophageal squamous cell carcinoma and adenocarcinoma Eur J Cardiothorac Surg, August 1, 2008; 34(2): 427 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kii, H. Takiuchi, S. Kawabe, M. Gotoh, S. Ohta, T. Tanaka, S. Kuwakado, H. Nishitani, and K.-i. Katsu Evaluation of Prognostic Factors of Esophageal Squamous Cell Carcinoma (Stage II III) After Concurrent Chemoradiotherapy Using Biopsy Specimens Jpn. J. Clin. Oncol., August 20, 2007; (2007) hym077v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ueda, A. Shiozaki, H. Itoi, K. Okamoto, H. Fujiwara, D. Ichikawa, S. Kikuchi, N. Fuji, T. Itoh, T. Ochiai, et al. The Range of Tumor Extension Should Have Precedence over the Location of the Deepest Tumor Center in Determining the Regional Lymph Node Grouping for Widely Extending Esophageal Carcinomas Jpn. J. Clin. Oncol., December 1, 2006; 36(12): 775 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mimura, K. Kono, M. Hanawa, M. Kanzaki, A. Nakao, A. Ooi, and H. Fujii Trastuzumab-Mediated Antibody-Dependent Cellular Cytotoxicity against Esophageal Squamous Cell Carcinoma Clin. Cancer Res., July 1, 2005; 11(13): 4898 - 4904. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Z. Atkins, A. S. Shah, K. A. Hutcheson, J. H. Mangum, T. N. Pappas, D. H. Harpole Jr, and T. A. D'Amico Reducing Hospital Morbidity and Mortality Following Esophagectomy Ann. Thorac. Surg., October 1, 2004; 78(4): 1170 - 1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Koshy, N. Esiashvilli, J. C. Landry, C. R. Thomas Jr., and R. H. Matthews Multiple Management Modalities in Esophageal Cancer: Epidemiology, Presentation and Progression, Work-up, and Surgical Approaches Oncologist, April 1, 2004; 9(2): 137 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tachibana, S. Kinugasa, H. Yoshimura, D. K. Dhar, and N. Nagasue Extended Esophagectomy With 3-Field Lymph Node Dissection for Esophageal Cancer Arch Surg, December 1, 2003; 138(12): 1383 - 1389. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Fang, H. Kato, Y. Tachimori, H. Igaki, H. Sato, and H. Daiko Analysis of pulmonary complications after three-field lymph node dissection for esophageal cancer Ann. Thorac. Surg., September 1, 2003; 76(3): 903 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hayashi, N. Ando, H. Watanabe, H. Ide, K. Nagai, N. Aoyama, W. Takiyama, K. Ishida, K. Isono, H. Makuuchi, et al. Phase II Evaluation of Protracted Infusion of Cisplatin and 5-Fluorouracil in Advanced Squamous Cell Carcinoma of the Esophagus: a Japan Esophageal Oncology Group (JEOG) Trial (JCOG9407) Jpn. J. Clin. Oncol., September 1, 2001; 31(9): 419 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Fang, H. Igaki, Y. Tachimori, H. Sato, H. Daiko, and H. Kato Three-field lymph node dissection for esophageal cancer in elderly patients over 70 years of age Ann. Thorac. Surg., September 1, 2001; 72(3): 867 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Igaki, H. Kato, Y. Tachimori, H. Sato, H. Daiko, and Y. Nakanishi Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection Eur J Cardiothorac Surg, June 1, 2001; 19(6): 887 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Fang, H. Kato, W. Chen, Y. Tachimori, H. Igaki, and H. Sato Comparison of Surgical Management of Thoracic Esophageal Carcinoma Between Two Referral Centers in Japan and China Jpn. J. Clin. Oncol., May 1, 2001; 31(5): 203 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lerut, W. Coosemans, P. De Leyn, G. Decker, G. Deneffe, and D. Van Raemdonck Is there a role for radical esophagectomy Eur J Cardiothorac Surg, September 1, 1999; 16(Supplement_1): S44 - S47. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. van de Ven, P. De Leyn, W. Coosemans, D. Van Raemdonck, and T. Lerut Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction{star} Eur J Cardiothorac Surg, June 1, 1999; 15(6): 769 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nakano, M. Baba, M. Shimada, K. Shirao, Y. Noguchi, C. Kusano, S. Natsugoe, H. Yoshinaka, T. Fukumoto, and T. Aikou How the Lymph Node Metastases Toward Cervico-Upper Mediastinal Region Affect the Outcome of Patients with Carcinoma of the Thoracic Esophagus Jpn. J. Clin. Oncol., May 1, 1999; 29(5): 248 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tabira, T. Okuma, K. Kondo, and N. Kitamura INDICATIONS FOR THREE-FIELD DISSECTION FOLLOWED BY ESOPHAGECTOMY FOR ADVANCED CARCINOMA OF THE THORACIC ESOPHAGUS J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 239 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tachimori, H. Kato, and H. Watanabe SURGERY FOR THORACIC ESOPHAGEAL CARCINOMA WITH CLINICALLY POSITIVE CERVICAL NODES J. Thorac. Cardiovasc. Surg., December 1, 1998; 116(6): 954 - 959. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lerut Esophageal surgery at the end of the millennium J. Thorac. Cardiovasc. Surg., July 1, 1998; 116(1): 1 - 20. [Full Text] |
||||
![]() |
F. H. Ellis Jr., G. J. Heatley, M. J. Krasna, W. A. Williamson, and K. Balogh ESOPHAGOGASTRECTOMY FOR CARCINOMA OF THE ESOPHAGUS AND CARDIA: A COMPARISON OF FINDINGS AND RESULTS AFTER STANDARD RESECTION IN THREE CONSECUTIVE EIGHT-YEAR INTERVALS WITH IMPROVED STAGING CRITERIA J. Thorac. Cardiovasc. Surg., May 1, 1997; 113(5): 836 - 848. [Abstract] [Full Text] |
||||
![]() |
Y. Tachimori, H. Kato, H. Watanabe, and H. Yamaguchi Neck ultrasonography for thoracic esophageal carcinoma Ann. Thorac. Surg., May 1, 1994; 57(5): 1180 - 1183. [Abstract] [PDF] |
||||
![]() |
T. Matsubara, M. Ueda, O. Yanagida, T. Nakajima, and M. Nishi How extensive should lymph node dissection be for cancer of the thoracic esophagus? J. Thorac. Cardiovasc. Surg., April 1, 1994; 107(4): 1073 - 1078. [Abstract] [Full Text] |
||||
![]() |
D. B. Skinner Invited letter concerning: How extensive should lymph node dissection be for cancer of the thoracic esophagus? J. Thorac. Cardiovasc. Surg., April 1, 1994; 107(4): 1154 - 1155. [Full Text] |
||||
![]() |
L. Berk and L. Coin The role of neck dissection in thoracic esophageal cancer Ann. Thorac. Surg., March 1, 1992; 53(3): 549 - 549. [PDF] |
||||
![]() |
H. Kato Reply Ann. Thorac. Surg., March 1, 1992; 53(3): 549 - 550. [PDF] |
||||
![]() |
D. B. Skinner Cervical lymph node dissection for thoracic esophageal cancer Ann. Thorac. Surg., June 1, 1991; 51(6): 884 - 885. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |